AUA Summit - AUA Disclosure Policy


AUA Disclosure Policy

All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors, reviewers) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners with information so they can make their own judgments.

Disclosures September Virtual Program

Education Council

COI Review work Group

Planners & Abstract Reviewers



Instructional Courses



Hands-on Courses

Disclosures for AUA2021 Summer School

AUA Guideline: Disorders of Ejaculation

Complications of Vaginal Mesh

Dust or Bust: A Beginner's Guide to Modern Day Laser Lithotripsy Strategies for Ureteroscopy

Evaluation and Management of Urinary Tract Bleeding: From Asymptomatic Microhematuria to Intractable Hemorrhagic Cystitis

Global Perspectives in Urethral Reconstruction

High Yield Review in Pediatric Urology

Management of Lower Urinary Tract Dysfunction after Prostate Cancer Treatment

Multispecialty Groups, Academic Health Systems and Private Equity: Choosing a Practice Model That Works for You

Nocturia: Advances in Diagnosis, Basic Science and Management

Should I be Ordering a Pet Scan?

Uro‐genital Tract Infections – Emerging Threats and Clinical Guidelines

Vasectomy: A Very Practical Case‐Based on Preoperative, Intraoperative and Postoperative Management

Disclosures for AUA2021 Kick-off Weekend

AUA Office of Education Staff has nothing to disclose.

Education Council Disclosures

COI Review Work Group Disclosures


Urologic Care for the Advanced Practice Provider Disclosures

Practice Management Program Disclosures

Contemporary Pharmacotherapy for OAB 2021: Monotherapy and Combined Pharmacotherapy to Optimize Treatment Disclosures

Diagnosis and Management of Localized, Locally Advanced and Advanced Kidney Cancer Disclosures

Trimodality Therapy for Management of Muscle Invasive Bladder Cancer Disclosures

Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider Disclosures

Incorporating Genomic Testing For Prostate Cancer Into Your Practice Disclosures

Urolithiasis: Metabolic Evaluation and Medical Management Disclosures

Perspectives on Increasing the Use of Palliative Care in Advanced Urologic Diseases Disclosures